2019年9月2日 星期一

慢性心臟衰竭處理 Chronic Heart Failure Management

ESC guideline 2016
Ref: 1. ESC guidelines, 2016, https://academic.oup.com/eurheartj/article/37/27/2129/1748921

Evidence of Survival benefit:
ACEI: Enalapril(Sintec, Synbot), Captopril(CEporin), Ramipril(Tritace), Trandolapril
ARB: Losartan(Cozaar), Valsartan(Diovan), Candesartan(Blopress), Telmisartan(Micardis) (ARB usage When ACEI is not tolerated)
Beta-blockers: Carvedilol(Dilatrend), Metoprolol(Betaloc), Bisoprolol(Concor)
MRA: Spironolactone(Aldactone), Eplerenone(Inspra)
If inhibitor: Ivabradine, Sinus rhythm, HR>=70bpm, LVEF<=35%
ARNI: Sacubitril/Valsartan(Entresto)

沒有留言:

張貼留言